NEW ORAL ANTICOAGULANTS FOR THROMBOPROPHYLAXIS AFTER TOTAL HIP OR KNEE REPLACEMENT: A META-ANALYSIS AND INDIRECT TREATMENT COMPARISONS

被引：0
|
作者：
Gomez-Outes, A. [1 ]
Terleira-Fernandez, A. [2 ]
Suarez-Gea, M. L. [1 ]
Vargas-Castrillon, E. [2 ]
机构：
[1] AEMPS, Madrid, Spain
[2] Hosp Clin San Carlos, Madrid, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2011年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [21] Economic Evaluations of New Oral Anticoagulants for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement: A Systematic Review
    James Brockbank
    Sorrel Wolowacz
    PharmacoEconomics, 2017, 35 : 517 - 535
  • [22] Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials
    Cao, Yong Bing
    Zhang, Jun Dong
    Shen, Hui
    Jiang, Yuan Ying
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (11) : 1099 - 1108
  • [23] Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials
    Ning, Guang-Zhi
    Kan, Shun-Li
    Chen, Ling-Xiao
    Lei Shangguan
    Feng, Shi-Qing
    Zhou, Yue
    SCIENTIFIC REPORTS, 2016, 6
  • [24] Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials
    Yong Bing Cao
    Jun Dong Zhang
    Hui Shen
    Yuan Ying Jiang
    European Journal of Clinical Pharmacology, 2010, 66 : 1099 - 1108
  • [25] Apixaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials
    Li Xiu-min
    Sun Shi-guang
    Zhang Wei-dong
    CHINESE MEDICAL JOURNAL, 2012, 125 (13) : 2339 - 2345
  • [26] Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials
    Guang-Zhi Ning
    Shun-Li Kan
    Ling-Xiao Chen
    Lei Shangguan
    Shi-Qing Feng
    Yue Zhou
    Scientific Reports, 6
  • [27] Clinical Experience With Novel Oral Anticoagulants for Thromboprophylaxis After Elective Hip and Knee Arthroplasty
    Messerschmidt, Cory
    Friedman, Richard J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (04) : 771 - 778
  • [28] Current Evidence and Expert Opinion on Thromboprophylaxis After Total Knee and Hip Replacement
    Mody, Bharat S.
    Wadhwa, Manuj
    Roy, Ronen
    Echila Sr, Shwetha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [29] NEW ORAL ANTICOAGULANTS ARE NOT SUPERIOR TO WARFARIN IN SECONDARY PREVENTION OF STROKE: INSIGHTS FROM A META-ANALYSIS OF RANDOMIZED TRIALS AND INDIRECT TREATMENT COMPARISONS
    Sardar, Partha
    Chatterjee, Saurav
    Wu, Wen-Chih
    Lichstein, Edgar
    Ghosh, Joydeep
    Aikat, Shamik
    Mukherjee, Debabrata
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E318 - E318
  • [30] Oral, direct factor XA inhibitor for thromboprophylaxis after total hip replacement
    Hulikova, M.
    Stasko, I
    Hulik, S.
    Hulikova, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 658 - 658
12345